![Peter Anastasiou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Anastasiou
Verksamhetschef på
HARMONY BIOSCIENCES HOLDINGS, INC.
Förmögenhet: - $ per 2026-07-31
Profil
Peter E.
Anastasiou is currently Director at Pharmaceutical Research & Manufacturers of America since 2017 and Chief Operating Officer at Harmony Biosciences Holdings, Inc. starting in 2026.
Former roles include Chief Executive Officer & Director at Capsida Biotherapeutics, Inc. from 2022 to 2025, Executive Vice President-North America at H.
Lundbeck A from 2009 to 2021, Marketing Director at Bristol Myers Squibb Co., Principal at Eli Lilly & Co., Vice President-Marketing at Neuronetics, Inc., and President at Lundbeck Seattle BioPharmaceuticals, Inc. Education includes an undergraduate degree from Albion College and an MBA from Kelley School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-02 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Peter Anastasiou
| Företag | Position | Start |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Verksamhetschef | 2026-04-02 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktör/Styrelseledamot | 2017-07-01 |
Tidigare kända positioner av Peter Anastasiou
| Företag | Position | Slut |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Verkställande Direktör | 2025-10-01 |
| H. LUNDBECK A/S | Företagsledare/Principal | 2021-12-31 |
| ALDER BIOPHARMACEUTICALS, INC. | President | - |
| ELI LILLY AND COMPANY | Företagsledare/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Försäljning & Marknadsföring | - |
Peter Anastasious utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
Albion College
 Albion College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
